Analyst Consensus ?
ConsensusBuy32 ratings
Bullish2475.0%
Neutral618.8%
Bearish26.2%
FN2 Earnings Intelligence
L3Harris Technologies, Inc. (LHX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Bernstein | Outperform | Outperform | Maintain | May 4, 2026 |
| UBS | Neutral | Neutral | Maintain | May 1, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Feb 5, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Feb 2, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jan 30, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 15, 2025 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2025 |
| Susquehanna | Positive | Positive | Maintain | Jul 25, 2025 |
| Baird | Outperform | Outperform | Maintain | Jul 25, 2025 |
| Goldman Sachs | Buy | Sell | Upgrade | Apr 11, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 8, 2025 |
| Jefferies | Buy | Buy | Maintain | Mar 31, 2025 |
| B of A Securities | Buy | Buy | Maintain | Feb 4, 2025 |
| Raymond James | Market Perform | Outperform | Downgrade | Jan 2, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Jan 2, 2025 |
| Argus Research | Buy | Hold | Upgrade | Nov 26, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Oct 10, 2024 |
| Alembic Global | Overweight | Neutral | Upgrade | Apr 22, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 1, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 12, 2023 |
| Benchmark | Hold | Buy | Downgrade | Apr 27, 2021 |
| Seaport Global | Buy | Buy | Maintain | May 19, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 16, 2020 |
| CFRA | Buy | Buy | Maintain | Feb 4, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Aug 8, 2019 |
| Vertical Research | Buy | Buy | Maintain | Jul 3, 2019 |
| Argus | Buy | Buy | Maintain | Apr 4, 2018 |
| Sterne Agee | Buy | Neutral | Upgrade | Feb 9, 2015 |
| Stifel Nicolaus | Hold | Hold | Maintain | May 21, 2013 |
| Oppenheimer | Underperform | Perform | Downgrade | Mar 6, 2013 |
| Lazard | Sell | Neutral | Downgrade | Oct 15, 2012 |
Upside is calculated against the persisted current price $297.53. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Gavin Parsons | $323 | $343.92 | +8.6% | Jan 14, 2026 |
| Truist Financial | Michael Ciarmoli | $364 | $343.76 | +22.3% | Jan 14, 2026 |
| Vertical Research | Robert Stallard | $355 | $350.48 | +19.3% | Jan 13, 2026 |
| Morgan Stanley | Analyst unavailable | $367 | $288.5 | +23.3% | Dec 16, 2025 |
| Morgan Stanley | Analyst unavailable | $350 | $299.99 | +17.6% | Oct 15, 2025 |
| Susquehanna | Charles Minervino | $300 | $260.96 | +0.8% | Jul 14, 2025 |
| Morgan Stanley | Kristine Liwag | $260 | $230.68 | -12.6% | Dec 19, 2024 |
| Jefferies | Sheila Kahyaoglu | $295 | $245.07 | -0.9% | Oct 30, 2024 |
| Citigroup | Jonathan Raviv | $291 | $244.52 | -2.2% | Oct 24, 2024 |
| Bernstein | Douglas Harned | $289 | $242.35 | -2.9% | Oct 11, 2024 |
| Wolfe Research | Myles Walton | $300 | $241.64 | +0.8% | Oct 10, 2024 |
| Deutsche Bank | Scott Deuschle | $250 | $244.66 | -16.0% | Oct 3, 2024 |
| Jefferies | Sheila Kahyaoglu | $275 | $230.09 | -7.6% | Aug 23, 2024 |
| RBC Capital | Sector Perform | $240 | $227.88 | -19.3% | Aug 14, 2024 |
| Morgan Stanley | Kristine Liwag | $257 | $230.62 | -13.6% | Aug 9, 2024 |
| Deutsche Bank | Scott Deuschle | $257 | $243.27 | -13.6% | Jul 26, 2024 |
| Deutsche Bank | Bryan Keane | $295 | $222.45 | -0.9% | Jun 19, 2024 |
| Wells Fargo | Matthew Akers | $245 | $214.75 | -17.7% | May 7, 2024 |
| Barclays | David Strauss | $245 | $217.06 | -17.7% | Apr 30, 2024 |
| RBC Capital | Ken Herbert | $250 | $215.63 | -16.0% | Apr 29, 2024 |
| US Capital Advisors | Peter Skibitski | $238 | $208.14 | -20.0% | Apr 22, 2024 |
| Robert W. Baird | Peter Arment | $219 | $180.12 | -26.4% | Oct 31, 2023 |
| Raymond James | Brian Gesuale | $210 | $174.36 | -29.4% | Oct 30, 2023 |
| Wells Fargo | Jonathan Raviv | $193 | $175.98 | -35.1% | Sep 18, 2023 |
| Wells Fargo | Matthew Akers | $209 | $172.72 | -29.8% | Sep 18, 2023 |
| Robert W. Baird | Peter Arment | $222 | $203.33 | -25.4% | Jul 26, 2023 |
| Credit Suisse | Scott Deuschle | $240 | $194.68 | -19.3% | Mar 27, 2023 |
| Wells Fargo | Analyst unavailable | $230 | $214.77 | -22.7% | Feb 1, 2023 |
| Cowen & Co. | Analyst unavailable | $240 | $199.91 | -19.3% | Jan 12, 2023 |
| Wells Fargo | Analyst unavailable | $219 | $201.95 | -26.4% | Jan 11, 2023 |
| Morgan Stanley | Analyst unavailable | $278 | $218.04 | -6.6% | Dec 15, 2022 |
| J.P. Morgan | Analyst unavailable | $250 | $215.61 | -16.0% | Dec 12, 2022 |
| RBC Capital | Ken Herbert | $285 | $231.97 | -4.2% | Aug 30, 2022 |
| Jefferies | Sheila Kahyaoglu | $300 | $235.21 | +0.8% | May 3, 2022 |
| Susquehanna | Analyst unavailable | $298 | $232.38 | +0.2% | May 2, 2022 |
| Raymond James | Analyst unavailable | $290 | $236.2 | -2.5% | Apr 29, 2022 |
| Jefferies | Sheila Kahyaoglu | $320 | $250.11 | +7.6% | Mar 14, 2022 |
| J.P. Morgan | Seth Seifman | $237 | $209 | -20.3% | Feb 1, 2022 |
| Susquehanna | Charles Minervino | $255 | $209 | -14.3% | Feb 1, 2022 |
| Wolfe Research | Michael Maugeri | $266 | $227.86 | -10.6% | Jan 14, 2022 |
| Goldman Sachs | Noah Poponak | $207 | $219.25 | -30.4% | Sep 23, 2021 |
| Cowen & Co. | Gautam Khanna | $250 | $219.05 | -16.0% | Sep 16, 2021 |
| Credit Suisse | Robert Spingarn | $254 | $226.35 | -14.6% | Aug 4, 2021 |
Track every rating change on LHX the moment it posts. Free to start.
Start free